Browsing by Author Grebely, Jason

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  
Showing results 1 to 20 of 22  next >
Issue DateTitleAuthor(s)Citation
2013Assessment and Treatment of Hepatitis C Virus Infection Among People Who Inject Drugs in the Opioid Substitution Setting: ETHOS StudyDay, Carolyn; Haber, Paul; Alavi, Maryam; Balcomb, Annie C.; Bath, Nicky; Dore, Gregory J.; Dunlop, Adrian J; Grebely, Jason; Micallef, Michelle; Treloar, Carla; Central Clinical School: Addiction Medicine; Central Clinical School: Addiction MedicineAssessment and Treatment of Hepatitis C Virus Infection Among People Who Inject Drugs in the Opioid Substitution Setting: ETHOS Study, Clinical Infectious Diseases, vol.57, Suppl 2, 2013,pp S62-S69
2012Effect of pegylated interferon alfa-2a treatment on mental health during recent hepatitis C virus infectionDay, Carolyn; Haber, Paul; Alavi, Maryam; Dore, Gregory; Grebely, Jason; Hellard, Margaret; Kaldor, John; Lloyd, Andrew; Matthews, Gail V; Petoumenos, Kathy; van Beek, I; Yeung, Barbara; Central Clinical School: Addiction Medicine; Central Clinical School: Addiction MedicineEffect of pegylated interferon alfa-2a treatment on mental health during recent hepatitis C virus infection, Journal of Gastroenterology and Hepatology, vol.27, 5, 2012,pp 957-965
2015The effect of social functioning and living arrangement on treatment intent, specialist assessment and treatment uptake for hepatitis C virus infection among people with a history of injecting drug use: The ETHOS studyDay, Carolyn; Haber, Paul; Alavi, Maryam; Balcomb, Annie C.; Bath, Nicky; Bruneau, Julie; Dore, Gregory; Dunlop, Adrian; Fortier, Emmanuel; Grebely, Jason; Micallef, Michelle; Treloar, Carla; Central Clinical School: Addiction Medicine; Central Clinical School: Addiction MedicineThe effect of social functioning and living arrangement on treatment intent, specialist assessment and treatment uptake for hepatitis C virus infection among people with a history of injecting drug use: The ETHOS study, International Journal of Drug Policy, vol.26, 11, 2015,pp 1094-1102
2015Effect of treatment willingness on specialist assessment and treatment uptake for hepatitis C virus infection among people who use drugs: The ETHOS studyDay, Carolyn; Haber, Paul; Alavi, Maryam; Balcomb, Annie C.; Bath, Nicky; Dore, Gregory J.; Dunlop, Adrian; Fortier, Emmanuel; Grebely, Jason; Micallef, Michelle; Treloar, Carla; Central Clinical School: Addiction Medicine; Central Clinical School: Addiction MedicineEffect of treatment willingness on specialist assessment and treatment uptake for hepatitis C virus infection among people who use drugs: The ETHOS study, Journal of Viral Hepatitis, vol.22, 11, 2015,pp 914-925
2010Effective Treatment of Injecting Drug Users With Recently Acquired Hepatitis C Virus Infection.Haber, Paul; McCaughan, Geoffrey; Dore, Gregory; et al, various; Grebely, Jason; Hellard, Margaret; Marks, Phillipa; Matthews, G; Petoumenos, Kathy; van Beek, I; White, Peter A; Yeung, B; Central Clinical School: Addiction Medicine; Central Clinical School: Centenary InstituteEffective Treatment of Injecting Drug Users With Recently Acquired Hepatitis C Virus Infection., Gastroenterology, vol.138, 1,pp 123-135.e1-2
2014The Effects of Female Sex, Viral Genotype, and IL28B Genotype on Spontaneous Clearance of Acute Hepatitis C Virus InfectionGeorge, Jacob; Amin, Janaki; Bruneau, Julie; Cox, Andrea; et al, Various; Grebely, Jason; Hajarizadeh, Behzad; Morris, Meghan; Page, Kimberly; Rice, Thomas; Sacks-Davis, Rachel; Schim van der Loeff, Maarten; Western Clinical School: Westmead Millennium InstituteThe Effects of Female Sex, Viral Genotype, and IL28B Genotype on Spontaneous Clearance of Acute Hepatitis C Virus Infection, Hepatology, vol.59, 1, 2014,pp 109-120
2017Efficacy of response-guided directly observed pegylated interferon and self-administered ribavirin for people who inject drugs with hepatitis C virus genotype 2/3 infection: The ACTIVATE studyWeltman, Martin; Backmund, Markus; Bruggmann, Philip; Conway, Brian; Cunningham, Evan B.; Dalgard, Olav; et al, Various; Foster, Graham R; Grebely, Jason; Hajarizadeh, Behzad; Robaeys, Geert; Nepean Clinical School: MedicineEfficacy of response-guided directly observed pegylated interferon and self-administered ribavirin for people who inject drugs with hepatitis C virus genotype 2/3 infection: The ACTIVATE study, International Journal of Drug Policy, vol.47, N/A, 2017,pp 177-186
2015Evaluation of two community-controlled peer support services for assessment and treatment of hepatitis C virus infection in opioid substitution treatment clinics: The ETHOS study, AustraliaDay, Carolyn; Bath, Nicky; Dore, Gregory; Everingham, Hope; Grebely, Jason; Hazelwood, Sue; Micallef, Michelle; Rance, Jake; Treloar, Carla; Central Clinical School: Addiction MedicineEvaluation of two community-controlled peer support services for assessment and treatment of hepatitis C virus infection in opioid substitution treatment clinics: The ETHOS study, Australia, International Journal of Drug Policy, vol.26, 10, 2015,pp 992-998
2015Excluding people who use drugs or alcohol from access to hepatitis C treatments - Is this fair, given the available data?Macneill, Paul Ulhas; Bruggmann, Philip; Byrne, Jude; Dore, Gregory; Grebely, Jason; Haire, Bridget; Levin, Jules; Litwin, Alain; Swan, Tracy; Taylor, Lynn; School of Public Health: Ctr for Values Ethics & Law in MedExcluding people who use drugs or alcohol from access to hepatitis C treatments - Is this fair, given the available data?, Journal of Hepatology, vol.63, 4, 2015,pp 779-782
2010Factors associated with uptake of treatment for recent hepatitis C virus infection in a predominantly injecting drug user cohort: The ATAHC StudyHaber, Paul; Dore, Gregory J.; Grebely, Jason; Hellard, Margaret; Kaldor, John M; Lloyd, Andrew; Marks, P; Matthews, G; Petoumenos, Kathy; Central Clinical School: Addiction MedicineFactors associated with uptake of treatment for recent hepatitis C virus infection in a predominantly injecting drug user cohort: The ATAHC Study, Drug and Alcohol Dependence, vol.107, 40239,pp 244-249
2017Hepatocellular carcinoma risk following direct-acting antiviral HCV therapy: A systematic review, meta-analyses, and meta-regressionGeorge, Jacob; Amin, Janaki; Danta, Mark; Dore, Gregory; Grebely, Jason; Hajarizadeh, Behzad; Law, Matthew; Waziry, Reem; Westmead Clinical School: Westmead Institute for Medical ResHepatocellular carcinoma risk following direct-acting antiviral HCV therapy: A systematic review, meta-analyses, and meta-regression, Journal of Hepatology, vol.67, 6, 2017,pp 1204-1212
2013High rates of hepatitis C virus reinfection and spontaneous clearance of reinfection in people who inject drugs: A prospective cohort studyGeorge, Jacob; Suppiah, Vijayaprakash; Atiken, Campbell; Bharadwaj, Mandvi; Bowden, S; Drummer, Heidi; Grebely, Jason; Hellard, Margaret; Higgs, Peter; Nivarthi, Usha; Pedrana, Alisa; Sacks-Davis, Rachel; Spelman, T; Western Clinical School: Westmead Millennium Institute; Western Clinical School: Westmead Millennium InstituteHigh rates of hepatitis C virus reinfection and spontaneous clearance of reinfection in people who inject drugs: A prospective cohort study, PLoS One, vol.8, 11, 2013,pp 1-12
2013Plasma interferon-gamma-inducible protein-10 (IP-10) levels during acute hepatitis C virus infectionGeorge, Jacob; Applegate, Tanya; Bruneau, Julie; Cherepanov, Vera; Dore, Gregory; Feld, Jordan; Grebely, Jason; Hellard, Margaret; Kaldor, John M; Lloyd, Andrew; Matthews, Gail; Petoumenos, Kathy; Shaw, Ineke; Sherker, Alana; Shoukry, Naglaa H.; Teutsch, Suzy; Yeung, Barbara; Zang, Geng; Western Clinical School: Westmead Millennium InstitutePlasma interferon-gamma-inducible protein-10 (IP-10) levels during acute hepatitis C virus infection, Hepatology, vol.57, 6, 2013,pp 2124-2134
2010Potential Role for Interleukin-28B Genotype in Treatment Decision-Making in Recent Hepatitis C Virus InfectionBooth, David; George, Jacob; Suppiah, Vijayaprakash; Applegate, Tanya; Dore, Gregory J.; Grebely, Jason; Hellard, Margaret; Kaldor, John M; Lloyd, Andrew R.; Marks, Phillipa; Matthews, Gail V; Petoumenos, Kathy; Rawlinson, William; Yeung, Barbara; Western Clinical School: Westmead Millennium Institute; Western Clinical School: Westmead Millennium Institute; Western Clinical School: Westmead Millennium InstitutePotential Role for Interleukin-28B Genotype in Treatment Decision-Making in Recent Hepatitis C Virus Infection, Hepatology, vol.52, 4, 2010,pp 1216-1224
2017Sequencing of Hepatitis C Virus for Detection of Resistance to Direct-Acting Antiviral Therapy: A Systematic ReviewDouglas, Mark; Applegate, Tanya; Bartlett, Sofia; Bull, Rowena; Ceccherini-Silberstein, Francesca; Dore, Gregory; Eltahla, Auda A; Feld, Jordan; Garcia, Federico; Grebely, Jason; Harrington, Patrick; Howe, Anita; Jacka, Brendan; Lennerstrand, Johan; Lloyd, Andrew R.; Matthews, Gail V; Miller, Veronica; Pawlotsky, Jean Michel; Reeves, Jacqueline; Schinkel, Janke; Wang, Gary; Westmead Clinical School: Westmead Institute for Medical ResSequencing of Hepatitis C Virus for Detection of Resistance to Direct-Acting Antiviral Therapy: A Systematic Review, Hepatology Communications, vol.1, 5, 2017,pp 379-390
2016Short duration response-guided treatment is effective for most individuals with recent hepatitis C infection: The ATAHC II and DARE-C i studiesHaber, Paul; Applegate, Tanya; Dore, Gregory J.; Grebely, Jason; Hellard, Margaret; Iser, David M.; Lloyd, Andrew; Maire, Laurence; Martinello, Marianne; Matthews, Gail; Petoumenos, Kathy; Sasadeusz, J; Shaw, David R; Thompson, Alexander; Yeung, Barbara; Central Clinical School: Addiction MedicineShort duration response-guided treatment is effective for most individuals with recent hepatitis C infection: The ATAHC II and DARE-C i studies, Antiviral Therapy, vol.21, 5, 2016,pp 425-434
2016Short duration response-guided treatment is effective for most individuals with recent hepatitis C infection: The ATAHC II and DARE-C i studiesHaber, Paul; Applegate, Tanya; Dore, Gregory J.; Grebely, Jason; Hellard, Margaret; Iser, David M.; Lloyd, Andrew; Maire, Laurence; Martinello, Marianne; Matthews, Gail; Petoumenos, Kathy; Sasadeusz, J; Shaw, David R; Thompson, Alexander; Yeung, Barbara; Central Clinical School: Addiction MedicineShort duration response-guided treatment is effective for most individuals with recent hepatitis C infection: The ATAHC II and DARE-C i studies, Antiviral Therapy, vol.21, 5, 2016,pp 425-434
2017Survival following hospitalization with hepatocellular carcinoma among people notified with hepatitis B or C virus in Australia (2000-2014)George, Jacob; Alavi, Maryam; Amin, Janaki; Dore, Gregory; Grebely, Jason; Hajarizadeh, Behzad; Law, Matthew; Matthews, Gail V; Waziry, Reem; Westmead Clinical School: Westmead Institute for Medical ResSurvival following hospitalization with hepatocellular carcinoma among people notified with hepatitis B or C virus in Australia (2000-2014), Hepatology Communications, vol.1, 8, 2017,pp 736-747
2016Time to decompensated cirrhosis and hepatocellular carcinoma after an HBV or HCV notification: a population-based study, 1995-2012George, Jacob; Alavi, Maryam; Amin, Janaki; Dore, Gregory; Grebely, Jason; Hajarizadeh, Behzad; Law, Matthew; Western Clinical School: Westmead Institute for Medical ResTime to decompensated cirrhosis and hepatocellular carcinoma after an HBV or HCV notification: a population-based study, 1995-2012, Journal of Hepatology, vol.65, 5, 2016,pp 879-887
2016Treatment for hepatitis C virus infection among people who inject drugs attending opioid substitution treatment and community health clinics: The ETHOS StudyDay, Carolyn; Haber, Paul; Weltman, Martin; Alavi, Maryam; Balcomb, Annie C.; Bath, Nicky; Dore, Gregory; Dunlop, Adrian; Grebely, Jason; Micallef, Michelle; Phung, Nghi; Treloar, Carla; Central Clinical School: Addiction Medicine; Central Clinical School: Addiction Medicine; Nepean Clinical School: MedicineTreatment for hepatitis C virus infection among people who inject drugs attending opioid substitution treatment and community health clinics: The ETHOS Study, Addiction, vol.111, 2, 2016,pp 311-319